Biomarkers have an essential role in diagnosis, management, risk stratification, and clinical decision-making for the patients suffering from various chronic diseases. Cardiac biomarkers are measurable and quantifiable biological parameters, which are detected in the blood and serve as indices for physiological and pathological assessments by a specialized immunoassay.
Latest development
In cardiovascular diseases, early diagnosis is critical for the treatment and survival of patients. A new strategy known as the high-sensitivity cardiac troponin T 1-hour algorithm could help physicians in treating patients with suspected heart attack faster, thus saving many lives. This strategy was researched on by a team of researchers from Switzerland and Spain in 2017.
Market Insights
In the global cardiac biomarker market, Asia-Pacific is poised to account approximately an 18.7% share in 2016, followed by America which holds a 49.60% of the market share.
Get the Full Report Here: https://www.mordorintelligence.com/industry-reports/cardiac-biomarkers-market
The major segmentation in the report includes by type of cardiac biomarker, which is further segmented into Creatine Kinase, Troponins (T,I), Myoglobin, Natriuretic peptides (BNP and NT-proBNP), Ischemia Modified Albumin, and others. On the basis of application, the market is further segmented into myocardial infarction, congestive heart failure, acute coronary syndrome, atherosclerosis, and others. On the basis of location of testing the market is segmented into point of care testing and laboratory testing and geography. The report provides in-depth analysis of cardiac biomarkers in the different geographical locations, namely North America, Europe, Asia-Pacific, the Middle East & Africa, and South America. The market segment of North America includes Canada, the United States, and Mexico. The European segment includes the United Kingdom, Germany, France, Italy, Spain, and the Rest of Europe. The Asia-Pacific segment includes Australia, New Zealand, China, India, Japan, South Korea, and the Rest of Asia-Pacific. The Middle East & Africa (MEA) segment includes GCC, South Africa, and the Rest of MEA. South America includes Brazil, Argentina, and the Rest of South America. The report also includes competitive vendor landscape while considering major companies, such as Abbott Laboratories, Alere Inc., Siemens Healthcare, Roche Diagnostics Corporation, Beckman Coulter Inc., Becton Dickinson and Company, and Thermo Fisher Scientific
About Mordor Intelligence
Mordor Intelligence is a market intelligence and business advisory firm. The company operates in the business of industry analysis & consulting, in over 16 verticals. In today’s fast-paced and competitive business environment, every customer has unique information requirements. With an eye to such requirements, Mordor offers custom market intelligence and advisory services along with syndicated reports, to help them gain an edge over the competition. The company has successfully catered to over 500 (40% of whom are Fortune 500) clients, since 2013.
For more information mail us at: https://www.mordorintelligence.com